Clinical trial
A Post-approval Study of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
NCT03063749 is registered in ClinicalTrials.gov with Medtronic Vascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Post-approval Study of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
- Lead sponsor
- Medtronic Vascular
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 30, 2017
- Completion date
- August 18, 2022
- Enrollment
- 416 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.